{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:01:43Z","timestamp":1790517703104,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Human polyomaviruses can reactivate in transplant patients, causing nephropathy, progressive multifocal leukoencephalopathy, Merkel cell carcinoma, pruritic, rash or trichodysplasia spinulosa. Sirolimus and related mechanistic target of rapamycin (mTOR) inhibitors are transplant immunosuppressants. It is unknown if they directly reactivate polyomavirus replication from latency beyond their general effects on immunosuppression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In vitro expression and turnover of large T (LT) proteins from BK virus, JC virus (JCV), Merkel cell polyomavirus (MCV), human polyomavirus 7 (HPyV7), and trichodysplasia spinulosa polyomavirus (TSV) after drug treatment were determined by immunoblotting, proximity ligation, replicon DNA replication, and whole virus immunofluorescence assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>mTOR inhibition increased LT protein expression for all 5 pathogenic polyomaviruses tested. This correlated with LT stabilization, decrease in the S-phase kinase-associated protein 2 (Skp2) E3 ligase targeting these LT proteins for degradation, and increase in virus replication for JCV, MCV, TSV, and HPyV7. Treatment with sirolimus, but not the calcineurin inhibitor tacrolimus, at levels routinely achieved in patients, resulted in a dose-dependent increase in viral DNA replication for BKV, MCV, and HPyV7.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>mTOR inhibitors, at therapeutic levels, directly activate polyomavirus replication through a Skp2-dependent mechanism, revealing a proteostatic latency mechanism common to polyomaviruses. Modifying existing drug regimens for transplant patients with polyomavirus-associated diseases may reduce symptomatic polyomavirus replication while maintaining allograft-sparing immunosuppression.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiaa071","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T20:10:06Z","timestamp":1581451806000},"page":"1160-1169","source":"Crossref","is-referenced-by-count":26,"title":["Sirolimus and Other Mechanistic Target of Rapamycin Inhibitors Directly Activate Latent Pathogenic Human Polyomavirus Replication"],"prefix":"10.1093","volume":"224","author":[{"given":"Jennifer","family":"Alvarez Orellana","sequence":"first","affiliation":[{"name":"Cancer Virology Program, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jin","family":"Kwun","sequence":"additional","affiliation":[{"name":"Cancer Virology Program, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Microbiology and Immunology, Pennsylvania State University, Hershey, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Artusi","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chang","sequence":"additional","affiliation":[{"name":"Cancer Virology Program, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Moore","sequence":"additional","affiliation":[{"name":"Cancer Virology Program, Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"2021101318473913600_CIT0001","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrmicro2992","article-title":"A cornucopia of human polyomaviruses","volume":"11","author":"DeCaprio","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"2021101318473913600_CIT0002","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0276","article-title":"Merkel cell polyomavirus and Merkel cell carcinoma","volume":"372","author":"DeCaprio","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2021101318473913600_CIT0003","doi-asserted-by":"crossref","first-page":"e0206273","DOI":"10.1371\/journal.pone.0206273","article-title":"Seroprevalence of fourteen human polyomaviruses determined in blood donors","volume":"13","author":"Kamminga","year":"2018","journal-title":"PLoS One"},{"key":"2021101318473913600_CIT0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13365-014-0234-x","article-title":"Reactivation of human polyomaviruses in immunocompromised states","volume":"20","author":"Wiedinger","year":"2014","journal-title":"J Neurovirol"},{"key":"2021101318473913600_CIT0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2017.12.004","article-title":"Merkel cell carcinoma: an update and review: current and future therapy","volume":"78","author":"Tello","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2021101318473913600_CIT0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2012.12.015","article-title":"Human polyomaviruses in disease and cancer","volume":"437","author":"Dalianis","year":"2013","journal-title":"Virology"},{"key":"2021101318473913600_CIT0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathol-011110-130227","article-title":"Merkel cell carcinoma: a virus-induced human cancer","volume":"7","author":"Chang","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"2021101318473913600_CIT0008","doi-asserted-by":"crossref","first-page":"16272","DOI":"10.1073\/pnas.0806526105","article-title":"T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus","volume":"105","author":"Shuda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021101318473913600_CIT0009","doi-asserted-by":"crossref","first-page":"926391","DOI":"10.1155\/2013\/926391","article-title":"A review on JC virus infection in kidney transplant recipients","volume":"2013","author":"Delbue","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2021101318473913600_CIT0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.semnephrol.2016.05.014","article-title":"BK and other polyomaviruses in kidney transplantation","volume":"36","author":"Trofe-Clark","year":"2016","journal-title":"Semin Nephrol"},{"key":"2021101318473913600_CIT0011","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1086\/431522","article-title":"Quantitation of DNA of polyomaviruses BK and JC in human kidneys","volume":"192","author":"Randhawa","year":"2005","journal-title":"J Infect Dis"},{"key":"2021101318473913600_CIT0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1474-4422(18)30040-1","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned","volume":"17","author":"Major","year":"2018","journal-title":"Lancet Neurol"},{"key":"2021101318473913600_CIT0013","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jlts.2001.24645","article-title":"mTOR inhibitors: an overview","volume":"7","author":"Neuhaus","year":"2001","journal-title":"Liver Transpl"},{"key":"2021101318473913600_CIT0014","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.1390055","article-title":"Calcineurin inhibitors: 40 years later, can\u2019t live without","volume":"191","author":"Azzi","year":"2013","journal-title":"J Immunol"},{"key":"2021101318473913600_CIT0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0009-9120(98)00048-4","article-title":"Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update","volume":"31","author":"Trepanier","year":"1998","journal-title":"Clin Biochem"},{"key":"2021101318473913600_CIT0016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0009-9120(98)00049-6","article-title":"Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus","volume":"31","author":"Oellerich","year":"1998","journal-title":"Clin Biochem"},{"key":"2021101318473913600_CIT0017","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of Merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"2021101318473913600_CIT0018","first-page":"CD004290","article-title":"Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients","volume":"12","author":"Hahn","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021101318473913600_CIT0019","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ijc.24510","article-title":"Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors","volume":"125","author":"Shuda","year":"2009","journal-title":"Int J Cancer"},{"key":"2021101318473913600_CIT0020","doi-asserted-by":"crossref","first-page":"E4040","DOI":"10.1073\/pnas.1703879114","article-title":"Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence","volume":"114","author":"Kwun","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021101318473913600_CIT0021","doi-asserted-by":"crossref","first-page":"e1004974","DOI":"10.1371\/journal.ppat.1004974","article-title":"A comprehensive analysis of replicating Merkel cell polyomavirus genomes delineates the viral transcription program and suggests a role for mcv-miR-M1 in episomal persistence","volume":"11","author":"Theiss","year":"2015","journal-title":"PLoS Pathog"},{"key":"2021101318473913600_CIT0022","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2008.11.001","article-title":"Merkel cell polyomavirus encodes a microRNA with the ability to autoregulate viral gene expression","volume":"383","author":"Seo","year":"2009","journal-title":"Virology"},{"key":"2021101318473913600_CIT0023","doi-asserted-by":"crossref","first-page":"12118","DOI":"10.1128\/JVI.01336-09","article-title":"The minimum replication origin of Merkel cell polyomavirus has a unique large T-antigen loading architecture and requires small T-antigen expression for optimal replication","volume":"83","author":"Kwun","year":"2009","journal-title":"J Virol"},{"key":"2021101318473913600_CIT0024","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.1000038","article-title":"Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2","volume":"7","author":"Feldman","year":"2009","journal-title":"PLoS Biol"},{"key":"2021101318473913600_CIT0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"2021101318473913600_CIT0026","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/12013","article-title":"SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27","volume":"1","author":"Carrano","year":"1999","journal-title":"Nat Cell Biol"},{"key":"2021101318473913600_CIT0027","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003088-200544080-00001","article-title":"Sirolimus: the evidence for clinical pharmacokinetic monitoring","volume":"44","author":"Stenton","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"2021101318473913600_CIT0028","doi-asserted-by":"crossref","first-page":"e13265","DOI":"10.1111\/ctr.13265","article-title":"Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia","volume":"32","author":"Knight","year":"2018","journal-title":"Clin Transplant"},{"key":"2021101318473913600_CIT0029","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/TP.0000000000001777","article-title":"The role of mTOR inhibitors in the management of viral infections: a review of current literature","volume":"102","author":"Bowman","year":"2018","journal-title":"Transplantation"},{"key":"2021101318473913600_CIT0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK polyomavirus replication in renal tubular epithelial cells is inhibited by sirolimus, but activated by tacrolimus through a pathway involving FKBP-12","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am J Transplant"},{"key":"2021101318473913600_CIT0031","doi-asserted-by":"crossref","first-page":"20180301","DOI":"10.1098\/rstb.2018.0301","article-title":"Intra-patient viral evolution in polyomavirus-related diseases","volume":"374","author":"McIlroy","year":"2019","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2021101318473913600_CIT0032","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.virol.2010.08.032","article-title":"A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV\/AIDS patient","volume":"407","author":"Broekema","year":"2010","journal-title":"Virology"},{"key":"2021101318473913600_CIT0033","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbrc.2016.01.076","article-title":"Ubiquitin ligase Fbw7 restricts the replication of hepatitis C virus by targeting NS5B for ubiquitination and degradation","volume":"470","author":"Chen","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"2021101318473913600_CIT0034","doi-asserted-by":"crossref","first-page":"18514","DOI":"10.1074\/jbc.M114.559930","article-title":"SCF-FBXO31 E3 ligase targets DNA replication factor Cdt1 for proteolysis in the G2 phase of cell cycle to prevent re-replication","volume":"289","author":"Johansson","year":"2014","journal-title":"J Biol Chem"},{"key":"2021101318473913600_CIT0035","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.celrep.2018.11.002","article-title":"The E3 ubiquitin ligases TRIM17 and TRIM41 modulate alpha-synuclein expression by regulating ZSCAN21","volume":"25","author":"Lassot","year":"2018","journal-title":"Cell Rep"},{"key":"2021101318473913600_CIT0036","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12732","article-title":"Smurf2 regulates stability and the autophagic-lysosomal turnover of lamin A and its disease-associated form progerin","volume":"17","author":"Borroni","year":"2018","journal-title":"Aging Cell"},{"key":"2021101318473913600_CIT0037","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2018.09.013","article-title":"Impact of immune suppressive agents on the BK-polyomavirus non coding control region","volume":"159","author":"Korth","year":"2018","journal-title":"Antiviral Res"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa071\/32841401\/jiaa071.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/7\/1160\/40632353\/jiaa071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/7\/1160\/40632353\/jiaa071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T06:16:00Z","timestamp":1634537760000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/7\/1160\/5736392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,2,15]]},"published-print":{"date-parts":[[2021,10,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa071","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2020,2,15]]}}}